amlodipine and atorvastatin

Generic: amlodipine and atorvastatin

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine and atorvastatin
Generic Name amlodipine and atorvastatin
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

amlodipine besylate 10 mg/1, atorvastatin calcium trihydrate 10 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-4517
Product ID 0378-4517_bee991e8-1686-425f-95cb-ff8d3133fffa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200465
Listing Expiration 2026-12-31
Marketing Start 2014-11-06

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs] hmg-coa reductase inhibitor [epc] hydroxymethylglutaryl-coa reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03784517
Hyphenated Format 0378-4517

Supplemental Identifiers

RxCUI
404011 404013 597967 597977 597980 597984 597987 597990
UPC
0303784519936 0303784514931 0303784520932 0303784516935 0303784517932 0303784515938 0303784518939 0303784513934
UNII
48A5M73Z4Q 864V2Q084H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and atorvastatin (source: ndc)
Generic Name amlodipine and atorvastatin (source: ndc)
Application Number ANDA200465 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4517-93)
source: ndc

Packages (1)

Ingredients (2)

amlodipine besylate (10 mg/1) atorvastatin calcium trihydrate (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bee991e8-1686-425f-95cb-ff8d3133fffa", "openfda": {"upc": ["0303784519936", "0303784514931", "0303784520932", "0303784516935", "0303784517932", "0303784515938", "0303784518939", "0303784513934"], "unii": ["48A5M73Z4Q", "864V2Q084H"], "rxcui": ["404011", "404013", "597967", "597977", "597980", "597984", "597987", "597990"], "spl_set_id": ["4be76756-4114-4d50-a36c-fd410f6c773d"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4517-93)", "package_ndc": "0378-4517-93", "marketing_start_date": "20141106"}], "brand_name": "Amlodipine and atorvastatin", "product_id": "0378-4517_bee991e8-1686-425f-95cb-ff8d3133fffa", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "0378-4517", "generic_name": "Amlodipine and atorvastatin", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and atorvastatin", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "10 mg/1"}], "application_number": "ANDA200465", "marketing_category": "ANDA", "marketing_start_date": "20141106", "listing_expiration_date": "20261231"}